Home/Filings/4/0001127602-23-028196
4//SEC Filing

Prindiville Mark Q 4

Accession 0001127602-23-028196

CIK 0000899051other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:40 PM ET

Size

12.4 KB

Accession

0001127602-23-028196

Insider Transaction Report

Form 4
Period: 2023-11-21
Transactions
  • Exercise/Conversion

    Common Stock

    2023-11-21$52.18/sh+4,016$209,55522,693 total
  • Exercise/Conversion

    Common Stock

    2023-11-21$70.71/sh+6,935$490,37429,628 total
  • Sale

    Common Stock

    2023-11-21$135.43/sh10,951$1,483,05218,677 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-11-214,0160 total
    Exercise: $52.18From: 2017-02-18Exp: 2024-02-18Common Stock (4,016 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-11-216,9350 total
    Exercise: $70.71From: 2018-02-18Exp: 2025-02-18Common Stock (6,935 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    0
Footnotes (1)
  • [F1]Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $135.19 to $135.59. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

Issuer

ALLSTATE CORP

CIK 0000899051

Entity typeother

Related Parties

1
  • filerCIK 0001811428

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:40 PM ET
Size
12.4 KB